SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009685
Filing Date
2016-11-08
Accepted
2016-11-08 16:30:01
Documents
90
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arlz-20160930x10q.htm 10-Q 1992014
2 EX-31.1 arlz-20160930ex311d24dae.htm EX-31.1 15379
3 EX-31.2 arlz-20160930ex3123f02d3.htm EX-31.2 19071
4 EX-32.1 arlz-20160930ex321693cbb.htm EX-32.1 11057
5 EX-32.2 arlz-20160930ex322f6045b.htm EX-32.2 11120
  Complete submission text file 0001558370-16-009685.txt   8601587

Data Files

Seq Description Document Type Size
6 EX-101.INS arlz-20160930.xml EX-101.INS 1774602
7 EX-101.SCH arlz-20160930.xsd EX-101.SCH 71834
8 EX-101.CAL arlz-20160930_cal.xml EX-101.CAL 74056
9 EX-101.DEF arlz-20160930_def.xml EX-101.DEF 303963
10 EX-101.LAB arlz-20160930_lab.xml EX-101.LAB 603307
11 EX-101.PRE arlz-20160930_pre.xml EX-101.PRE 526696
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4
Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37691 | Film No.: 161981612
SIC: 2834 Pharmaceutical Preparations